Handbook of HER2-targeted agents in breast cancer

Mostrar otras versiones (1)

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year.  Of these cases, approximately  15-25% overexpress HER2, a transmembrane RTK kinase that is associated with aggress...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Alvarez, Ricardo H. (Autor), Cortés, Javier (Autor), Mattos-Arruda, Leticia (Autor), Falzon, Mary (Autor), Fasolo, Angelica (Autor), Gandy, Michael (Autor), Gianni, Luca (Autor), Harbeck, Nadia (Autor), Piccart, Martine (Autor), Zambelli, Stefania (Autor), Zardavas, Dimitrios (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Tarporley : Springer Healthcare Ltd. : Imprint: Springer Healthcare, 2013.
Edición:1st ed. 2013.
Temas:
Oncology.
Primary care (Medicine).
Family medicine.
Internal medicine.
Therapeutics.
Primary Care Medicine.
General Practice and Family Medicine.
Internal Medicine.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Introduction and background biology
  • HER2 testing
  • HER2-positive breast cancer: adjuvant and neoadjuvant therapy
  • HER2-positive metastatic breast cancer: first-line treatment
  • HER2-positive metastatic breast cancer: second-line treatment
  • Emerging targeted agents for HER2-positive breast cancer.

Ejemplares similares